#latest in oncology

[touchaheartnews]

Five Recent Breakthroughs in the Battle Against Cancer

From combining treatments in unprecedented ways to deploying artificial intelligence for personalised medicine, a raft of new advances in the fight against cancer have been presented at the European Society for Medical Oncology (ESMO), which ends on Tuesday. Here are some of the big announcements made at the five-day conference held in the Spanish city of Barcelona, which brought together 30,000…

[drchandrakant01]

Latest Research in Oncology Interventions: What’s New in 2024?

The field of oncology is perpetually evolving, with groundbreaking research and innovative interventions transforming cancer treatment. As we step into 2024, the advancements in oncology are more promising than ever, offering new hope to patients worldwide. This blog explores the latest research in oncology interventions, highlighting significant breakthroughs and their potential impact on cancer care.

Immunotherapy: The Frontier of Cancer Treatment

Immunotherapy continues to be at the forefront of oncology, harnessing the body’s immune system to fight cancer. In 2024, several novel immunotherapy approaches are making waves in cancer treatment.

Personalized Cancer Vaccines: Personalized cancer vaccines are designed to train the immune system to recognize and attack specific cancer cells. Recent studies have shown that these vaccines can induce robust immune responses, particularly in melanoma and lung cancer patients. The vaccines are tailored to individual patients based on the genetic makeup of their tumors, making them highly specific and effective.

Bispecific T-cell Engagers (BiTEs): BiTEs are engineered antibodies that bind to both cancer cells and T-cells, bringing them into close proximity to enhance the immune response against cancer. The latest research indicates that BiTEs are showing promising results in treating hematologic malignancies, such as leukemia and lymphoma, and solid tumors like colorectal and breast cancers.

CAR-T Cell Therapy Enhancements: Chimeric Antigen Receptor T-cell (CAR-T) therapy has been a game-changer for certain types of blood cancers. In 2024, enhancements to CAR-T cell therapy, including the development of allogeneic (off-the-shelf) CAR-T cells and the incorporation of novel targets, are expanding its applicability to a broader range of cancers, including solid tumors.

Precision Medicine: Targeted Therapies Evolving

Precision medicine aims to tailor treatments to the individual characteristics of each patient’s cancer. The latest research in 2024 is pushing the boundaries of targeted therapies.

Liquid Biopsies for Early Detection: Liquid biopsies, which analyze circulating tumor DNA (CTDNA) in the blood, are becoming increasingly sophisticated. Recent advancements have improved their sensitivity and specificity, allowing for earlier detection of cancer and monitoring of treatment response. Liquid biopsies are particularly beneficial for detecting minimal residual disease (MRD) and guiding treatment decisions in real time.

Next-Generation Sequencing (NGS): NGS technology is enabling comprehensive genomic profiling of tumors, identifying actionable mutations and guiding targeted therapy. In 2024, the integration of NGS into clinical practice is more widespread, helping oncologists tailor treatment plans based on the genetic alterations specific to each patient’s cancer. This approach is proving especially effective in treating cancers with rare mutations.

Poly (ADP-ribose) Polymerase (PARP) Inhibitors: PARP inhibitors, initially approved for BRCA-mutated ovarian and breast cancers, are now showing efficacy in other cancer types, including prostate and pancreatic cancers. Research in 2024 is focusing on combining PARP inhibitors with other therapies, such as immunotherapy, to enhance their effectiveness and overcome resistance.

Advances in Radiation Therapy

Radiation therapy remains a cornerstone of cancer treatment, and recent advancements are enhancing its precision and reducing side effects.

Proton Therapy: Proton therapy is a type of radiation that uses protons instead of X-rays to treat cancer. The precision of proton therapy allows for higher doses of radiation to be delivered to tumors while sparing surrounding healthy tissue. In 2024, proton therapy is being utilized more extensively for treating pediatric cancers and tumors located near critical structures, such as the brain and spine.

MR-Linac Systems: Magnetic Resonance Linear Accelerator (MR-Linac) systems combine MRI imaging with linear accelerator radiation delivery, allowing for real-time visualization of tumors during treatment. This technology is improving the accuracy of radiation therapy, particularly for tumors that move with respiration, such as lung and liver cancers.

Stereotactic Body Radiotherapy (SBRT): SBRT delivers highly focused radiation beams to small, well-defined tumors, offering high doses of radiation with minimal impact on surrounding tissues. In 2024, SBRT is being increasingly used for treating oligometastatic disease (limited metastatic tumors) and certain primary cancers, such as early-stage lung cancer and prostate cancer.

Novel Drug Therapies and Combinations

The development of new drugs and combination therapies is accelerating, providing more options for cancer patients.

Antibody-Drug Conjugates (ADCs): ADCs are targeted cancer therapies that deliver cytotoxic drugs directly to cancer cells via monoclonal antibodies. In 2024, new ADCs are showing significant promise in treating various cancers, including breast, bladder, and lung cancers. These therapies are designed to improve efficacy while minimizing systemic toxicity.

Combination Therapies: Combining different treatment modalities, such as immunotherapy with targeted therapy or chemotherapy, is a major focus in oncology research. Recent studies have demonstrated that combination therapies can enhance treatment responses and overcome resistance mechanisms. For instance, combining PD-1/PD-L1 inhibitors with VEGF inhibitors has shown improved outcomes in renal cell carcinoma and hepatocellular carcinoma.

Epigenetic Therapies: Epigenetic therapies, which target the mechanisms that regulate gene expression, are emerging as a promising avenue for cancer treatment. In 2024, researchers are investigating drugs targeting histone deacetylases (HDACs) and DNA methyltransferases (DNMTs) to reverse abnormal gene expression patterns in cancer cells and suppress tumors.

Conclusion

The latest research in oncology interventions in 2024 is paving the way for more effective, personalized, and less toxic cancer treatments. From innovative immunotherapies and precision medicine advancements to cutting-edge radiation techniques and novel drug therapies, the future of cancer care looks brighter than ever. These advancements not only offer new hope for patients but also underscore the importance of ongoing research and collaboration in the fight against cancer. As we continue to unravel the complexities of cancer, the progress made in 2024 brings us one step closer to achieving better outcomes and improving the quality of life for cancer patients worldwide.

[thewitfire]

Latest Cancer Cure News 2023: Advances in Oncology

Latest Cancer Cure News 2023: Advances in Oncology. #cancernews #latestcancernews #oncology #pharmanews

Latest Cancer Cure News 2023: As we progress through 2023, the field of oncology continues to witness groundbreaking advancements that are reshaping the landscape of cancer treatment. These developments not only offer new hope to patients worldwide but also signify the relentless efforts of the scientific community in their quest to conquer cancer. This article delves into some of the most…

[market-insider]

AI-Powered Analytical Solutions for Oncology: The Next Step in Cancer Research

The global AI in oncology for analytical solutions market size is expected to reach USD 7.4 billion by 2030. The increasing demand to reduce healthcare costs is expected to be a crucial factor driving the adoption of artificial intelligence (AI) in oncology for analytical solutions. The implementation of artificial intelligence algorithms in oncology can significantly improve the accuracy of procedures and reduce the costs associated with treatment by avoiding unnecessary tests. For instance, a June 2021 study published in Frontiers found that incorporating artificial intelligence in the diagnosis of colorectal cancer helped save around USD 400 million, primarily due to the early detection of cancer.

Gain deeper insights on the market and receive your free copy with TOC now @: AI In Oncology For Analytical Solutions Market Report

The high prevalence of cancer-related diseases worldwide is expected to drive the expansion during the forecast period. For example, the American Cancer Society, Inc. estimates that by the end of 2022, there will be nearly 1.9 million new diagnoses and 609,360 cancer-related deaths in the U.S. Additionally, lung, breast, rectal, and colon cancers were the most common cancers in February 2022, according to the World Health Organization. Moreover, a third of global cancer deaths are attributed to high body mass index, tobacco use, and lack of physical activity. Therefore, the increasing prevalence of this disease globally is expected to increase the adoption of artificial intelligence for more accurate diagnosis, contributing to the growth of the AI in oncology analytical solutions market.

The market is anticipated to grow due to improvements in healthcare infrastructure and the increasing prevalence of cancer. By utilizing artificial intelligence technology, healthcare providers can diagnose and plan treatment procedures with greater ease. The use of artificial intelligence enables earlier and more accurate detection, reducing treatment costs and enhancing the patient experience through personalized treatment. Additionally, the growth is fueled by initiatives from government and non-government organizations that invest in healthcare R&D. For instance, the Indian government plans to introduce healthcare infrastructure programs worth USD 6.8 billion, according to a recent report from IBEF.

[darkmaga-retard]

2nd Smartest Guy in the World

Aug 14, 2024

The coverups must continue when it comes to all things slow kill bioweapon “vaccines,” with the latest assassination of doctors willing to expose the global PSYOP-19 eugenics project being yet another case in point; to wit:

In the recent airplane crash in São Paulo, Brazil, six prominent scientists were among the victims. The crash occurred on August 9, 2024, and involved a Voepass ATR 72 twin-engine plane carrying 61 (2SG: 62) people. Among those who perished were eight doctors heading to an oncology conference, which included the six scientists. The identified scientists include: 1. Dr. José Roberto Leonel Ferreira, a senior radiologist who had a significant impact in the field of radiology, particularly in pediatric radiology. 2. Dr. Mariana Belim, an intensivist in the Adult ICU at the Western Paraná University Hospital (Huop). 3. Dr. Ariane Risso, also from the Uopeccan Cancer Hospital in Cascavel. 4. Edilson Hobold, a professor of physical education. 5. Deonir Secco, a professor of agricultural engineering. 6. Raquel Ribeiro Moreira, a literature professor at the Cascavel campus. These individuals were respected professionals in their respective fields and were traveling to share their knowledge and expertise at the conference Source

[imaginemalereader]

Anonymous request: Imagine working for House and having a crush on Wilson

“You agree with me, right?”

The question directed at you snapped you out of your thoughts. Chase was staring at you and you had unfortunately no clue what he was arguing with House over.

“I’m not sure I completely follow.” You replied.

“The patient has all the signs of lupus.” Chase said, quickly running down the list.

“It’s not lupus. It’s never lupus!” House exclaimed.

You studied the differential on the board. While House was sure it was never lupus, you had to agree with Chase that the symptoms lined up.

“It’s always possible that it’s something else, but I do agree with Chase. It is hitting all the classic marks. Do you have a different suggestion?”

“Run the damn tests. You’ll see I’m right and then we can move on from this bad idea and get to a real answer.” House threw his hands in the air and limped away to his office.

“[Y/N], why don’t you and Cameron go run the tests. Chase and I can try to find whatever it is that House thinks we should be finding.” Foreman suggested.

You and Cameron nodded and headed out of the space. As you walked the halls she made some small talk.

“So what were you thinking about when Chase asked for your input?” She asked.

“What do you mean?” You asked, trying to play it off.

“Oh come on, we both know you weren’t listening to what he said.”

“I was just, um, running through the differential in my,” you got distracted as the two of you passed Dr. Wilson in the hall. He smiled and gave you a quick wave as he walked toward his office. You smiled and waved back, knowing your cheeks were heating up in spite of yourself.

“I think I have a better idea what was running through your head.” Cameron said with a laugh.

“What? You think...? Don’t be ridiculous.” You blustered trying to defend yourself but you knew it wasn’t doing any good.

“You’ve got a thing for Wilson.”

“I, uh, may have something of a crush.” You admitted.

“So when are you going to tell him?” She asked, enjoying the new development, not that she hadn’t had her suspicions before. You always got shy when the oncologist was around and picked his suggestions over House’s even though you worked for House.

“Oh you know I was thinking, never.”

“No, [Y/N], you have to tell him.”

“No I definitely do not. He’s the head of oncology and I’m still an intern. And I don’t even know if he likes guys.”

“Well you’ll never know if you don’t ask.”

“Yes and that way he’ll never know either. And I don’t have to worry about dying of embarrassment. I’m perfectly happy waving in the halls and talking at lunch sometimes.”

Cameron shook her head but by that point you were arriving at the patient’s room. You both knew she wasn’t going to just drop it though.

A few days later, you went to lunch alone and sat down to eat a quick meal before getting back to your latest case. Your plan was interrupted when none other than James Wilson approached your table.

“Mind if I join you?” He asked, gesturing to the empty seat across from you.

“Not at all.” You said immediately.

“How are you doing?” He asked as he sat down.

“Good. Taking my breaks where I can get them. House doesn’t always, how do I put this, remember that humans need to eat.”

Wilson laughed. He knew that all too well about House.

“I’m just glad he’s at least remembering you guys are humans.”

“Well, he sometimes remembers that.” You replied. “House is a genius and it’s obviously a huge privilege to work for him but, I don’t want to talk bad about your friend.” You realized in the middle of your sentence maybe you shouldn’t be saying this to him.

“House is an ass, believe me I know. And whatever you’re going to say I’m sure  I’ve heard worse said about him.”

“I wish he was a little nicer. I know we’re still learning but would a genuine compliment kill him?”

“I think it might.” Wilson said with a smile. “But in all seriousness, I can talk to him if you want. He shouldn’t be so cruel. You don’t deserve that.”

“We both know it won’t change anything.” You said with a shrug. You were flattered that he offered though. But, considering he was friends with House you figured he would do that for anyone House was bothering.

“Maybe not, but I’d hate to see you get down because House can’t be bothered to respect you.”

“I guess you probably see enough sad people every day, huh?” You replied, once again trying to deflect the thoughts that he was talking about you specifically.

“Sure, but it always makes my day a little better when you wave at me in the hall.”

You felt your face heat up. You tried to tell yourself it was just a friendly compliment. But no matter how many times your brain said it, your heart was still jumping.

“I, thank you.” You replied, not certain how to respond. “I like it when you smile, it’s good to see a kind face around.”

Wilson’s face was now getting a pink tint to it. He was about to say something more when his pager beeped.

“I’m sorry, I’ve got to-”

“Of course, go.” You interrupted.

He got up and moved to leave before turning back around to you.

“Do you want to grab dinner later? I’d like to talk without these interruptions for once.”

“I’d love to.” You were positively beaming.

“It’s a date.” He said without thinking. He met your eyes quickly. You had a shy smile on your face and looked down from him. “Sorry I shouldn’t have-”

“It’s okay. It’s a date.” You cut him off with a smile.

He smiled back, that cute gentle smile of his.

“I’ll see you this evening then. For our date.” He nodded, and turned to leave again. You both did little celebrations once the other couldn’t see.

You’d never wanted a shift to end so fast in your life. House seemed intent on making every minute feel like an hour. But eventually the end came and you had to fight not to sprint to Wilson’s office.

The door was open but you knocked lightly anyway when you saw him hunched over papers. He looked up and then looked at his watch.

“I’m sorry,” you began, “if you’re too busy we don’t have to-”

“Nope, I’m glad you came. Otherwise I might have just dived into the endless pile of paperwork and never come back.” He stood up, grabbed his coat off the back of his chair and walked toward you. “How do you feel about Italian?”

“I’m a big fan of Italian.”

“Good, I know a place.”

You walked out of the hospital together and he led the way down the street.

“Did you actually mean for this to be a date? Or was that just a turn of phrase?” You ended up asking partway down the street after a few seconds of silence. You were nervous. In the moment it had felt cute but now you were doubting again.

Wilson paused before answering.

“If you want it to be a date, it’s a date. I meant it when I said it but then I was worried it was too forward.”

“Okay good.” You said.

“Good.”

“Yeah good. I do want it to be a date then.”

“Good.”

He smiled and reached over, taking your hand. He looked over at you and you smiled before looking away. Cameron would never let you hear the end of this. But you were on a date with James Wilson so you couldn’t really be mad about it.

[thelovelymissbigbadwolf]

Still thinking about Nurse/Dr Fair and since I'm a sucker for him undeniably being drawn to tragedy I'm making oncologist Fair au

Decided to cure cancer when he was 9 and his favorite relative died

Studied as hard as he could, BARELY passing on medicine on Shinra, like, BY A SINGLE POINT

He studied even harder now that he had his ADHD diagnosis and watched Patch Addams and got heavily inspired

Was planning on just being general surgeon, but watched House and liked Wilson, so he decided to follow a old dream of his

Became a resident at the ripe age of 23, VERY young, yes.

Spent a few years on residence until he finally got to follow on oncology

His first case was a old man with stage four lung cancer.

He passed away from a aneurysm, Zack was understandably devastated by it, but didn't let that get him down.

Later in his career, he got his youngest case, a new born

It progressed very quickly and the baby couldn't make it, unfortunately

He had to take a while off after it, a weekend with friends and family helped him lots

He goes to every single one of his patient's funeral and makes sure to cover all burial expenses for the family.

Latest in his life, he was casually chatting with a friend who had a really bad stomach ache (you can guess who it is) and he told him to get it checked just in case

A few days later, his newest case arrived. Stage four gastric cancer, patient name: Cloud Strife.

[tomorrowusa]

Trump's pal Vladimir Putin is back to bombing children's hospitals in Ukraine. Putin can't understand why Ukrainians won't let him take over their country. So he's killing as many of their children as possible as retribution.

Russian missile strike partially destroyed a children’s hospital in Kyiv on Monday, causing terrified patients and their families to flee for their lives, as officials fear more people could be trapped beneath the rubble. Moscow launched a brazen daytime aerial assault on targets in cities across Ukraine during morning rush hour, killing at least 36 people and injuring 137 others, according to Ukraine’s emergency service. The large scale bombardment struck areas in the capital, as well as in Dnipro, Kryvyi Rih, Slovyansk and Kramatorsk. In an update on Telegram, the emergency service said the latest figure included the number of dead and injured in the capital, which now stands at 22 people killed. Two people were killed and at least 16 were injured in the strike on Kyiv’s Okhmatdyt hospital. The facility is Ukraine’s largest children’s medical center and has been vital in the care of some of the sickest children from across the country. Every year, around 7,000 surgeries – including treatments for cancer and hematological diseases – are conducted at the hospital, according to Ukraine’s human rights ombudsman Dmytro Lubinets. Videos from the scene showed volunteers working with police and security services to sift through the rubble as smoke billowed from the hospital, as staff described how they tried to rush children to safety in the wake of the attack. Ukraine’s health minister Viktor Liashko said intensive care units, oncology departments and surgery units had been damaged.

US Republicans and others from the radical right around the world back Putin. They bizarrely see him as "strong" despite the incompetent way he's conducted his war and the enormous losses Russia has sustained.

To give you a ground level view of how Russia is actually doing in its shabby unprovoked war, the Washington Post published intercepts of communications by Russian troops during their failed Kharkiv offensive.

Russian ground troops are poorly trained, poorly armed, and poorly supplied. Putin just mindlessly throws troops at Ukraine the way Trump throws ketchup at walls.

The Russian population is kept ignorant of massive losses and is fed histrionic nationalistic propaganda on state TV. Internet access to Western news sites blocked. Putin mouthpieces dressed like James Bond villains openly promote additional war crimes.

Russia is not a normal country and it is not led by a normal person.

Despite what tankies and far right Putin apologists may tell you, Russia has no fucking business in Ukraine.

[amanrathour]

Showering Hope: Dr. Manoj Kr. Sharma Offers the Best Radiation Oncology Treatment in Delhi NCR

The world is united together to find the cure for cancer and the day a cure could be invented is not far ahead but about to knock our door. With the latest breakthroughs in research and development for cancer treatments worldwide radiation oncology is more precise and advanced with the cutting-edge technology of the 21st century.

The desperate fight against cancer begins with the search for perfect treatment and the best oncologist who can understand and eliminate cancer cells from the root cause for no recurrence. For patients who want the very Best Radiation Oncology in Delhi NCR, there is no better person to turn to and consult than Dr Manoj Kr. Sharma who is internationally renowned for his capabilities and compassionate care in the field of cancer treatments.  Dr. Sharma is the best oncologist in Delhi for radiation oncology services that give hope and restore life to a healthy one for cancer patients globally.

Dr. Manoj Sharma Oncology - Best Radiation Oncology in Delhi NCR

Dr. Manoj Kr. Sharma, the top oncologist of Delhi NCR has a lot of experience in Oncology. Dr. Sharma is an experienced radiation oncologist with international expertise in providing state-of-the-art treatments that target cancerous cells precisely and accurately. Dr. Sharma has many years of experience in understanding the complicated nature of not only cancer care but also combining state-of-the-art technologies and unique creative techniques to craft personalized treatment plans for every patient and also accurately diagnose cancer at its earliest stages for a definite cure.

Benefits for Cancer Patients:

1. Personalized Treatment Plans: Dr. Sharma realizes that no two cancer cases are identical and neither should the treatment be the same. Therefore, he adopts a patient-based treatment approach, by evaluating every patient’s condition and developing personalized plans for radiation therapy which will maximize effectiveness while minimizing any side effects and promising a swift recovery towards a healthy future.

2. Advanced Technology: Dr. Sharma uses the latest technological developments in radiation oncology to treat cancerous cells with high accuracy and focus on the absolute annihilation of cancer infection. Patients receive advanced treatments with IMRT to IGRT, which are leading-edge techniques designed for perfection in effective treatment outcomes and promoting a healthier tomorrow.

3. Compassionate Care: Besides offering excellent oncological care, Mr. Manoj Kr.  is loved for his compassionate and kind approach to cancer care, along with unfailing support toward his or her patients. He gives them important time and a patient ear to listen and understand their worries, address their fears and encourage them with the required support to help them take on their cancer-defeating journeys with strength and perseverance.

4. Comprehensive Approach: According to Dr. Sharma, the treatment of cancer should be not limited to radiation therapy only, but it should also include a combination of complementary therapies, medically evaluated nutritional support and regular psychosocial services in an integrated approach to cure the disease. By treating not only the major chemical aspects but also the physical, emotional and psychological aspects of cancer treatment for cancer patients he creates a more holistic approach which benefits patients in their recovery process.

Conclusion:

Within the unyielding fight against cancer, hope enlightens the way, guiding us to a world where we can live without this daunting enemy called cancer. Dr. Manoj Kumar Sharma is leading the charge in this battle, with his radiation oncology treatments in Delhi NCR. Radiotherapy has undergone revolutionary changes with technological developments and the development of science and research, it is now more effective and accurate than ever before. Dr. Sharma’s expert knowledge and caring approach represent the highest standards in cancer care, which gives patients plans for personalized treatment that takes into account the peculiarities of a person to provide maximum positive output.

When the world of cancer treatment still stands at a crossroads, Dr. Sharma’s dedication to quality oncology treatment solutions is a light that shines on and leads patients sailing safely through the sea of hope towards the future in which cancer is extinct. As shown by Dr. Sharma and the team, a cancer-free world is now closer than it has ever been through harnessing cutting-edge technologies. For more information or to schedule a consultation with Dr. Manoj Kr. Sharma, please visit https://www.drmanojsharmaoncology.com/ or Action Cancer Hospital, Delhi NCR.

[thewitfire]

Latest Cancer Cure News 2023: Breakthroughs in Oncology

Latest Cancer Cure News 2023: Breakthroughs in Oncology. #cancernews #LatestCancerCureNews2023

Latest Cancer Cure News 2023: The year 2023 has been a landmark year in the field of oncology, witnessing several groundbreaking advancements in cancer research and treatment. These developments offer new hope and expanded treatment options for patients battling various forms of cancer. This article delves into some of the most significant breakthroughs that have emerged this year, marking a new…

[market-insider]

Hemato Oncology Testing Market: Technological Advancements and Competitive Landscape

Hematological oncology testing, also known as hemato-oncology testing, refers to a range of diagnostic tests and techniques used in the field of oncology to assess and monitor blood cancers and related hematological disorders. These tests are essential for accurate diagnosis, disease monitoring, treatment selection, and predicting patient outcomes. The applications of hemato-oncology testing encompass various aspects of patient care. One primary application is the detection and classification of hematological malignancies, such as leukemia, lymphoma, and myeloma. These tests help identify specific genetic and molecular alterations in cancer cells, which play a crucial role in disease diagnosis, prognosis, and treatment decision-making. Hemato-oncology testing also aids in distinguishing between different subtypes of blood cancers, guiding targeted therapies and personalized treatment approaches.

Gain deeper insights on the market and receive your free copy with TOC now @: Hemato Oncology Testing Market Report

Furthermore, these tests are vital for disease monitoring and assessing treatment response. Regular monitoring of specific genetic markers and biomarkers associated with hematological malignancies allows healthcare providers to evaluate the effectiveness of therapy, adjust treatment plans, and detect minimal residual disease (MRD). MRD testing is especially important in assessing the presence of small numbers of cancer cells that may remain after treatment and help determine the risk of relapse. In addition to diagnosis and monitoring, hemato-oncology testing plays a crucial role in identifying potential genetic predispositions to blood cancers. Genetic testing can uncover hereditary mutations or alterations that increase an individual's susceptibility to developing hematological malignancies, aiding in proactive screening, risk assessment, and counseling for patients and their families. The end-users of hemato-oncology testing include hospitals, diagnostic laboratories, research institutions, and pharmaceutical companies. These entities rely on these tests to provide accurate diagnoses, guide treatment decisions, support clinical trials, and drive research advancements in the field of hematological oncology. Hemato-oncology testing is an integral part of comprehensive cancer care, facilitating precision medicine approaches and improving patient outcomes in the management of blood cancers.

Liquid biopsy has emerged as a promising non-invasive diagnostic tool in hemato-oncology testing. It involves analyzing circulating tumor cells (CTCs), cell-free DNA (cfDNA), or exosomes in a patient's blood sample to detect genetic mutations, chromosomal abnormalities, or other biomarkers associated with blood cancers. Liquid biopsy has the potential to provide real-time monitoring of disease progression and treatment response, as well as aid in early detection of minimal residual disease (MRD). Next-Generation Sequencing (NGS) technologies have advanced significantly in recent years, enabling comprehensive genomic profiling of hematological malignancies. NGS-based panels can simultaneously analyze multiple genes or regions of interest, allowing for the identification of genetic alterations, gene fusions, and mutations associated with specific blood cancers. NGS platforms are increasingly being adopted in clinical settings to guide treatment decisions, monitor disease evolution, and detect potential drug resistance.

Minimal Residual Disease (MRD) Monitoring testing has gained importance in hemato-oncology to assess the presence of residual cancer cells after treatment. Traditional methods, such as flow cytometry and polymerase chain reaction (PCR), have been enhanced with more sensitive techniques like next-generation flow cytometry (NGF) and digital PCR (dPCR). These approaches provide greater accuracy in detecting low levels of residual disease, aiding in treatment decisions, prognostication, and early intervention to prevent relapse. Immunohistochemistry (IHC) and Fluorescence In Situ Hybridization (FISH) techniques have been extensively used in the diagnosis and classification of hematological malignancies. Recent advancements in these technologies, including the development of new antibodies and probes, have improved their sensitivity and specificity. IHC and FISH play a vital role in identifying specific proteins or genetic alterations in cancer cells, assisting in accurate diagnosis and targeted therapy selection. The integration of AI and ML algorithms into hemato-oncology testing has the potential to enhance data analysis, improve accuracy, and facilitate personalized treatment decisions. These technologies can assist in identifying complex genetic patterns, predicting patient outcomes, and optimizing treatment strategies based on large-scale genomic data and clinical information.

[ramesh2202]

MGM Cancer Institute: Best Cancer Hospital in Chennai, India

MGM Cancer Institute stands as a beacon of hope and healing for cancer patients in Chennai, India. As one of the best cancer hospitals in the region, the institute is renowned for its specialized doctors and comprehensive services in the field of oncology. With a commitment to excellence, a multidisciplinary approach, and state-of-the-art facilities, MGM Cancer Institute offers a range of advanced treatments for various types of cancer. Let's delve into the key aspects that make MGM Cancer Institute a leader in cancer care.

Specialized Doctors in Oncology:

MGM Cancer Institute houses a team of highly specialized doctors in various oncology disciplines. These dedicated experts bring their expertise to the forefront of cancer treatment.

Comprehensive Cancer Services:

The institute offers a wide spectrum of cancer services, including: Surgical Oncology Targeted Therapy Immunotherapy Chemotherapy Radiation Therapy This comprehensive approach ensures that patients receive the most effective and personalized treatment.

Expertise in Various Cancer Types:

MGM Cancer Institute excels in treating a diverse range of cancers, including but not limited to: Pancreatic Cancer Head & Neck Cancer Endocrine Cancer Cervical Cancer Prostate Cancer Lung Cancer Stomach Cancer Skin Cancer Thyroid Cancer Breast Cancer Colorectal Cancer Bladder Cancer Blood Cancer

Cutting-Edge Technology:

State-of-the-art diagnostic and treatment facilities enable precise diagnosis and treatment planning. Advanced imaging technologies aid in early cancer detection.

Multidisciplinary Approach:

MGM Cancer Institute follows a multidisciplinary approach to cancer care. A collaborative team of oncologists, surgeons, radiologists, pathologists, and support staff ensures holistic care for patients.

Patient-Centric Care:

Patient comfort and well-being are paramount at MGM Cancer Institute. Supportive care services, including counseling and nutritional guidance, enhance the overall quality of life during treatment.

Commitment to Research:

The institute actively engages in cancer research and clinical trials. This commitment to innovation ensures that patients have access to the latest advancements in cancer treatment.

Comprehensive Cancer Center:

MGM Cancer Institute functions as a comprehensive cancer center, offering a wide range of services under one roof. This approach streamlines the treatment process for the convenience of patients and their families.

Recognized Excellence:

MGM Cancer Institute is recognized as one of the best cancer hospitals in Chennai, India. Its dedication to excellence in cancer care has earned it a reputation of trust and reliability.

A Trusted Name in Cancer Care:

For those facing a cancer diagnosis, MGM Cancer Institute is a trusted destination for top-quality cancer treatment and care.

It serves as a symbol of hope and healing, providing comprehensive solutions for cancer patients. cancer hospital in Chennai, cancer treatment Chennai, best cancer hospital in Chennai, cancer center in Chennai, cancer institute Chennai, cancer specialist hospital in Chennai

In conclusion, MGM Cancer Institute in Chennai, India, is a testament to the power of specialized expertise, advanced technology, and patient-centered care in the fight against cancer. As a leading cancer hospital in the region, MGM Cancer Institute continues to make significant strides in cancer research and treatment, offering hope and support to individuals and families affected by cancer. Contact For Appointment +91 44 4251 5151

[darkmaga-retard]

The Defender’s Children’s Health NewsWatch delivers the latest headlines related to children’s health and well-being, including the toxic effects of vaccines, drugs, chemicals, heavy metals, electromagnetic radiation and other toxins and the emotional risks associated with excessive use of social media and other online activities. The views expressed by other news sources cited here do not necessarily reflect the views of The Defender. Our goal is to provide readers with breaking news about children’s health.

by The Defender Staff

August 6, 2024

[mingunissi]

She smiled at him, the kind of smile that he would see in the parents of his patients. How absurd. He clenched his fist to his side and forced his own onto his lips as he tried to reign in his composure. Mingun stood there and looked at his mother for the first time in twenty-seven years. ‘Song Ji Young, my mother. Beautiful, powerful but so damn cruel.’ Mingun thought bitterly. He would just offer her a smile, a polite nod and clipped answers whenever he was addressed. Yet he could still feel her eyes on him, it was intense and stifling. 

There was a bit of commotion inside the doctor’s lounge when Mingun clocked in for his shift that morning. Everyone was busy talking with each other, a discussion that was important that garnered the attention of the majority of the morning shift. While the morning shift turnover was usually noisy, it wasn’t like this. This wasn’t the typical morning that he had been accustomed to since he began in fellowship in this hospital. It struck him as weird, and being naturally curious he wanted to at least have some context on the latest happenings. 

Fortunately, he spotted a familiar intern and quickly called him over. “Hey Jinho-ah! What’s going on? Why is everyone so… so animated? It’s not even 9 in the morning.” He asked the intern. The intern only shrugged apologetically. “I’m not sure myself but from what I heard, someone from a conglomerate visited the director. Obviously, the flock will be interested.” 

“I heard it’s Chairwoman Song. Song Ji Young of Songsan. Not sure, but I think it’s her.”  

Mingun froze. Songsan. Song Ji Young. The very name that his late matron had uttered in her deathbed. His biological mother. 

He quickly excused himself from the rest of the floor and locked himself in his office. He felt chilled–down to his bones. The cold dread came crashing down and slowly swallowing him. 

That person is here. Why? 

Mingun thought that he had buried the knowledge of his birth mother in the deepest of his mind. He didn’t find the importance of it now. He had long lost interest in the idea of a family–of her. But the resentment, the anger , the loneliness and the pain that he had to go through remained under his skin, shimmering steadily and never really cooled. 

A knock from his door forced him to push his thoughts back. “Dr Lee? The medical director wants to see you.” He looked up, his eyes wide. Why? Why would the medical director want to see him? A newly minted oncology fellow? Surely it was not because of her? But at the back of his mind, and as much as he wanted to deny that thought of it – he had very strong inkling that it was because of that. She couldn’t possibly know… right? Mingun sighed as he resigned himself to a meeting that he didn't want. A meeting that he could live without having. 

“Color me surprised when the director asked for you. I mean I’m sure it’s nothing big, you’re just a newbie…” He ignored his senior’s ramblings clearly the hospital had done the older wrong for calling for a green eared fellow over him. How pathetic and despicable, Mingun couldn’t care less about his senior’s pride. He couldn’t care less about anything at all. 

He squared his shoulders as he entered the room. The chilled air conditioned air bit in his skin as he walked in. He kept his eyes downcasted and proceeded to bow deep in greeting.  “You called for me sir? Lee Mingun from the Oncology department.” He didn’t dare look anywhere but to his boss but he could feel the burning eyes of that person. There was no doubt about it. It really was Song Ji Young. He peeked at her and bowed as well. She smiled at him, the kind of smile that he would see in the parents of his patients. How absurd. He clenched his fist to his side and forced his own onto his lips as he tried to reign in his composure. Mingun stood there and looked at his mother for the first time in twenty-seven years. ‘Song Ji Young, my mother. Beautiful, powerful but so damn cruel.’ Mingun thought bitterly. He would just offer her a smile, a polite nod and clipped answers whenever he was addressed. Yet he could still feel her eyes on him, it was intense and stifling. 

“Lee Mingun. What a clever name. Who gave it to you?” He turned to the woman, there was something about the way she said his name… “My old matron did.  I grew up in an orphanage you see…” There was a bit of satisfaction in seeing the slight flinch that she did after his response. All the more reason to believe that she knew who he was.  “How… How old are you now if you don’t mind me asking.” she pressed on. 

“Twenty-seven ma’am.” Her eyes turned teary this time. “I see…” The satisfaction was absent, instead he felt curious at her reaction. By then there were only the two of them left in the room, his boss had left them to talk. This wasn’t the way Mingun imagined he would meet his mother for the first time. While his emotions are still going haywire, the anger has settled into a cold and unfeeling indifference. It was the first tear that really put him into the edge, she was crying now and her hand was shaky against her lap. 

There was a tense silence between the two, for Mingun, being in her presence was painful and he wanted out. “If you have nothing more to say then I’ll head on–” He cleared his throat and moved to stand up only to be stopped by the other. 

“No. Please, stay for a bit. I… I have something to say.”  Ji Young met his own orbs and squared her shoulders.

“Yi Jung. Song Yi Jung, that’s the name of my son.”

Song Yi Jung. It rolled beautifully in his tongue yet it left a bitter taste. Yi Jung. The name that was supposed to be his – not the nameless orphan that he had been. 

“I had him when I was still in college. I was young and immature and his father was a force of nature; and just like that I have him growing inside of me.” At this point, Ji Young was shaky, tears dripped freely from her eyes yet she couldn’t bring herself to look at him. Mingun wanted to hear this. His childish dream of knowing the reason why he was abandoned was unraveling right there and then.  “I don’t understand why…” Mingun whispered. “Why tell me this?” 

Suddenly, Ji Young reached for his hand and held it tightly with hers. “Yi Jung-ah.” Mingun froze. He wanted to pull away but suddenly he couldn’t.

“It’s you. You’re Song Yi Jung. My son.” She reached for him and pressed her hand on the side of his face. Mingun remained frozen, the cold indifference that he held quickly melting. He glared at her. 

Something must have clicked in her mind that made her pull away. With a shaky breath she asked. “You knew?” Mingun only nodded. He stood up finally and turned away from her as the pain of the years of loneliness came truly crashing down. “Of course I knew.”

“How? I… How?” Ji Young stammered. “My old matron, she told me.” There were so many things that he wanted to say, but he remained mum. “I have known about it for a while now.” Mingun then faced his mother. “You left something when you abandoned me. That was your mistake. You should have made sure that you didn’t leave anything behind on something that you were going to leave behind.” 

Ji Young shook her head with her eyes screwed shut in pain. Mingun’s words surely had stung but what he had said were words that he had wanted to say. And still he wasn’t finished. 

“You don’t have to worry though. I’ll keep this secret until the end. I didn’t need a mother all my life and you standing here for whatever reason will not change that fact.” 

“Yi Jung-ah… Mingun-ah… I’m sorry… I did’t mean to–!” 

“Didn’t mean what? Get willingly pregnant and then leave your infant outside of an orphanage in the middle of winter? Didn’t mean to abandon your child? It was your choice.” Mingun’s voice was low. He kept his gaze on the older woman, who obviously was trying her hardest to keep herself together. It was painful to watch and Mingun had enough. He knew that this conversation was far from over but for now this is enough. 

“If you’re here to make sure that I won’t tell anyone about my identity. Like I said, you don’t have to worry. My name is Lee Min Gun. And it will always be Lee Min Gun.”